Skip to content
Screener

GeneDx Holdings WGS Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$17.74M-264%-$63.32M-870%-$17.67M—-$7.64M+8.1%$10.81M+137%
$6.71M+8.4%$6.81M+19.9%$6.88M+23.8%$6.47M+9.2%$6.19M+18.6%
$6.34M-18.8%$9M+126%$9.78M+244%$10.59M+191%$7.81M+151%
-$28.98M-378%-$32.41M-418%$0+100%$15.77M+459%$10.42M+331%
$10.11M+327%$6.45M+5.3%$4.35M+42.5%$6.17M+855%$2.37M+75.2%
-$5.63M+84.5%-$17.26M-83.4%-$11.07M-2,033%-$4.69M+39.6%-$36.35M-60.1%
——————————
$1.01M+190%$38.59M+181%$23.19M-25.2%$10.77M-22.9%$346K+188%
-$33.61M-31.4%-$11.07M-176%$9.03M—$21.85M—-$25.58M+7.3%
-$39.1M-586%-$38.86M-1,059%——$9.6M+290%$8.05M+237%

FAQ

How much cash does GeneDx Holdings generate?
GeneDx Holdings (WGS) generated -$45.6M in operating cash flow over the trailing twelve months.
What is GeneDx Holdings's free cash flow?
After $27.1M of capital expenditures, GeneDx Holdings's free cash flow was -$72.7M over the trailing twelve months, down 8860.0% year over year.
Where does GeneDx Holdings's cash flow data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.